We are thrilled to have Dr. Emily Drabant Conley, Vice President of Business Development, 23andMe in the panel discussion “The Road to Personalized Medicine.” 23andMe is a personal genomics pioneer and now one of the “unicorns,” which are startups valued at $1 billion or more. See Dr. Emily Drabant Conley’s bio here.